Skip to main content

Bridgebio therapeutics logo

Special Report: The latest addition to the partner portfolio all the way from Asia Pacific. A warm welcome to Bridge Biotherapeutics, for which CEO, James Lee, commented: “In joining BaseLaunch, centered in the Basel Area, a major hub for life sciences innovation in Europe, our team is very excited to explore new opportunities of discovering promising therapeutic ventures and supporting exceptional seed-stage biotech companies developing sciences into novel therapeutics.” Read the full press release where you can hear from Stephan Emmerth, Director Business Development and Operations at BaseLaunch, and Christopher Kim, board member of Bridge Biotherapeutics, on the partnership.  


Read the full press release here.


Share this article

View all news

Sign up to receive our newsletter in your inbox.